Research in the Department of Psychiatry
A Wide-Ranging Research Portfolio
The Mass General Department of Psychiatry’s wide-ranging research portfolio spans clinical and basic research on virtually every major psychiatric disorder. These initiatives typically began as clinical trials conducted in clinical units and expanded to observational and mechanistic studies with notable expansions in genetics, neuroimaging and basic neuroscience. This model of cross-talk between clinical care and science has consistently led to research advances.
Our neuroscience, neuroimaging, and genetic research programs include clinical and translational researchers whose work is informed and motivated by the unmet needs of our patient populations.
The integration of patient care and clinical research has been a hallmark of the Department of Psychiatry for more than 30 years.
#2 in Psychiatry
U.S. News & World Report rates Mass General Psychiatry among the top in the nation.
Advances in Motion
Advances in Motion highlights the latest breakthroughs, research and clinical trials from Mass General.
Over 60 specialty psychiatry clinical and research programs
We provide care for patients of any age throughout the lifespan.
Clinical Trials Network & Institute (CTNI)
The Clinical Trials Network & Institute offers world-class services for drug development and clinical trials success.
The Clinical Trials Network & Institute ensures that our innovative research methods are unmatched in helping sponsors meet their research goals.
Pioneering Neuroscience Research
As a world leader in medical discovery and patient care, Mass General Neuroscience brings together the expansive expertise and passion from our Psychiatry, Neurosurgery and Neurology Departments. Through Advances in Motion, we provide health care professionals with information about our latest breakthroughs, research and clinical advances.